Article
Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA.
Molecular cell - 16 Jan 2009
Hartsuiker Edgar, Neale Matthew J, Carr Antony M
Abstract excerpt
For a cancer cell to resist treatment with drugs that trap topoisomerases covalently on the DNA, the topoisomerase must be removed. In this study, we provide evidence that the Schizosaccharomyces pombe Rad32(Mre11) nuclease activity is involved in the removal of both Top2 from 5' DNA ends as well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
